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Abstract Controlling melanogenesis is important for
maintaining the good health and cosmetic appearance of a
human body. This study aims to search the active com-
pounds from natural products exhibiting the melanogenesis
modulating activity and elucidate the mechanism under-
lying the observed activity. Two novel quercetin glycosides
namely 40-O-b-D-glucopyranosyl-quercetin-3-O-b-D-glu-
copyranosyl-(1 ? 4)-b-D-glucopyranoside 1 and 40-O-b-
D–glucopyranosyl-(1 ? 2)-b-D-glucopyranosyl-quercetin-
3-O-b-D-glucopyranosyl-(1 ? 4)-b-D-glucopyranoside 2
were isolated and identified from Helminthostachys zey-
lanica roots 50 % ethanol extract. Compound 1 exhibited
intracellular melanogenesis stimulatory activity, while 2
showed no effect even the structural similarity. To under-
stand the structure–activity relationships, twelve quercetin
glycosides and seven methylquercetins were synthesized
from rutin as starting material. As the result of bioassay
using synthesized nineteen quercetin derivatives in B16
melanoma cells, some quercetin-3-O-b-D-glucopyranosides
stimulated the intracellular melanogenesis. On the other
hand, synthesized 3-O-methylquercetin 12 and 3,40,7-O-
trimethylquercetin 15 increased both intra and extracellular
melanin contents with no cytotoxicity. Compoud 15 in-
creased the phosphorylated p38 mitogen-activated protein
kinase (MAPK) and microphthalmia-associated
transcription factor (MITF) which regulates the expression
of tyrosinase, TRP-1 and TRP-2. While 12 enhanced the
expression of the melanogenic enzymes without involving
the MITF, as evidenced by its lack of any stimulation of the
expression of MITF and p-p38 MAPK. This result indicates
that 12 may stimulate the expression of tyrosinase, TRP-1,
and TRP-2 by stimulating currently unidentified tran-
scriptional factors and/or by regulating the degradation of
melanogenic enzymes.
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Melanin biosynthesis
Melanin pigment is distributed in several tissues in the
human body. The main function of melanin is considered to
prevent skin damage by ultraviolet (UV) rays including in
sunlight [1, 2]. The excess accumulation of melanin or the
absence of melanin production caused by aging, strass, and
UV damages induces gray hairs, freckles, mottling, and
senile lentigines [3]. Hence, regulating melanogenesis is
desired to maintain the good health and cosmetic appear-
ance of the human body. Keratinocytes, existing on the skin
surface, produce messengers such as a-melanocyte-s-
timulating hormone (a-MSH), prostaglandin, and histamine
to melanocytes after stimulated by UV irradiation [4]. Then,
melanocyte biosynthesizes the melanin in melanosome and
transports the mature melanosomes to the keratinocytes.
The skin pigmentation is induced by the cornification of
keratinocyte including the mature melanosomes that are
biosynthesized and transported by the melanocytes (Fig. 1).
Similarly, hair pigmentation occurs due to melanin released
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on the outside of the melanocyte. During active growth of
hair follicles, melanocytes locate in the hair blub prolifer-
ated and differentiate to produce pigment of the hair shaft
[5, 6]. Melanocytes begin to shut down melanogenesis in
late anagen and regression phase called catagen, and it die
by apoptosis on the hair bulb in rest phase called telogen.
The melanogenesis in melanocytes reappears when hair
follicles reenter anagen [7–10]. The prevention of me-
lanogenesis in the hair bulb on anagen is induced by the
aging or stress which results in gray hair.
Melanin biosynthesis initially takes place via oxidation
of L-tyrosine catalyzed by tyrosinase in melanosome, a rate
limiting reaction of melanin biosynthesis (Fig. 2). Tyrosi-
nase catalyzes the hydroxylation of L-tyrosine to L-3,4-di-
hydroxyphenylalanine (L-DOPA), as well as the subsequent
oxidation of L-DOPA to L-DOPA quinone [11, 12]. Ty-
rosinase contains two copper ions, and inactive tyrosinase is
activated via taking in oxygen and H2O. The active ty-
rosinase binds with tyrosine or L-DOPA and release the
oxidized product via constitution of intermediate. Two
types of melanin are ultimately biosynthesized, reddish-
orange and blackish-brown pigments called pheomelanin
and eumelanin, respectively, with the enzymes tyrosinase-
related protein (TRP)-1 and TRP-2 playing a key role in the
biosynthesis of eumelanin [13]. Then regulation of tyrosi-
nase, TRP-1, and TRP-2 activity and/or expressions plays
an important role in controlling melanin production.
Transcriptional regulation of melanogenesis
The expressions of melanogenic enzymes, tyrosinase, TRP-
1, and TRP-2, are transcriptionally regulated by microph-
thalmia-associated transcription factor (MITF) and several
kinds of kinase pathway [14–17] as shown in Fig. 3. The
amounts of cyclic adenosine monophosphate (cAMP) in
melanocyte is increased by the messenger such as his-
tamine, a-MSH, tumor necrosis factor (TNF)-a, interleukin
(IL)-1b, and prostaglandin released by keratinocyte after
get stimulated by UV [4, 18, 19]. The effects of messengers
are induced via interaction with receptors on the me-
lanocytes. Melanocortin 1 receptor (MC1R), a receptor of
a-MSH, leads to elevation of cAMP contents by the in-
teraction with a-MSH.
The increase of cAMP contents results in the regulation
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activated protein kinase (MAPK), extracellular signal-
regulated kinase (ERK), and c-Jun N-terminal kinase
(JNK) which regulate the expressions of melanogenic en-
zymes [20]. PKA phosphorylates the cAMP response ele-
ment-binding protein (CREB), which is known to be an
activator of MITF expression [16, 21–23]. Phosphorylated
p38 MAPK stimulates the expression of melanogenic en-
zymes via activating the MITF expression [24, 25]. Addi-
tionally, p38 MAPK regulates melanogenesis by
stimulating proteasomal degradation of melanogenic en-
zymes [26]. ERK phosphorylates more than 160 proteins,
including transcription factors, enzymes, protein kinase
relating to signal transduction, and so on, and it ultimately
down regulates the expression of MITF and melanogenesis
[27–30]. JNK, involved in proliferation and apoptosis
cancer cells, also controls the melanogenesis by down-
regulating the expression of MITF [31–33].
Melanogenesis controlling effect of medicinal
plants extract
Medicinal plants have been traditionally used to maintain
good health and beauty on human body such as curing the
inflammatory, preventing microbial infection, skin
whitening, etc. Indonesian tropical forests, containing
28,000 plant species, cover about 143 million hectares and
are home to about 80 % medicinal plants in the world.
Jamu, an Indonesian traditional herbal medicine, have been
generally used in Indonesia so far. For instance, a Jamu
including Trigonella foenum graecum, Tribulus terrestris,
Yohimbe, Talinum paniculatum, and Plantago major have
been used to treat liver and kidney disturbance. Orthosi-
phonis, Phyllanthi, Plantaginis, Blumeae, Centellae, Mor-
indae, Alstoniae, Andrographidis, and Cercospora apii
have been used for treating mild hypertension, and Mor-
indae fructus, Orthosiphonis folium, Syzygii polyanthi,
Andrographidis, Centellae, and Curcumae have been used
to treat diabetes mellitus [34].
To clarify the mechanism of the biological activity of
Jamu, the biological activity of Indonesian medicinal
plants extracts has been investigated, and isolation and
identification of bioactive components including Indone-
sian medicinal plants have been performed in the world
because of its valuable pharmaceutical potential. A number
of bioactivity of Indonesian medicinal plants have been
reported and novel compounds and bioactive components
have been isolated from Indonesian herbal medicinal plants
used as Jamu. Kamiya et al. [35] isolated five novel fla-
vonoid glucuronides from fruit of Helicteres isora which is
called Ulet–Ulet in Java island and used as Jamu in In-
donesia. A novel anthraquinone glucoside was isolated
from the root of Rheum palmatum, an Indonesian Jamu
[36]. The extracts of traditional Indonesian medicinal
plants, Cinnamomum massoiae, Eucalyptus globulus, Vitex
trifolia, Eucalyptus globulus, Plantago major L., and Vitex
trifolia L. inhibit the histamine release from rat basophilic
leukemia cells [37]. In this study, the lead compounds
exhibiting melanogenesis controlling effect was searched
using Helminthostachys zeylanica, an Indonesian medic-
inal plant.
Traditional medicinal plants have been used for cos-
metics especially for whitening agents. As described
above, melanin is synthesized via rate limiting reaction by
tyrosinase catalysis from L-tyrosine as a starting material.
Hence a number of extracts of medicinal plants and the
components have been treated to determine the tyrosinase
inhibitory activity in order to search the whitening agents.
Morin as shown in Fig. 4, one of the flavonol and widely
distributed in plants including onion, guava leaves and
seaweeds, exhibits potent tyrosinase inhibitory activity [38,
39]. Glabridin, an isoflavan derivatives, was isolated from
Allamanda cathartica stem as potent tyrosinase inhibitor
[40, 41]. Artocarbene, chlorophorin, norartocarpanone, and
4-propylresorcinol including 2,4-substituted resorcinol
moiety induce high tyrosinase inhibitory activity [42, 43].
Catechol moiety of chalcone exhibits tyrosinase inhibitory
activity, and it is reported that the catechol chelates with
the copper ions, present in the active site of tyrosinase.
While the 2, 4-substituted resorcinol shows no chelate with
the copper ions and inhibits tyrosinase activity more po-
tently than catechol by competitive binding with the copper
ions in tyrosinase. The tyrosinase activity and melano-
genesis of prenylated flavonoids from Artocarpus altilis
were determined [44]. A. altilis is popularly known as the
breadfruit tree in English. Besides the leaves, roots, and
root bark are used as traditional medicines in West Indies
to relieve asthma, decrease blood pressure, cure liver dis-
orders, and decrease fever [45]. Norartocarpetin from A.
altilis also including 2, 4-substituted resorcinol moiety
exhibits potent tyrosinase inhibitory activity as well as
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While artocarpin which has 2, 4-substituted moiety shows
less potent tyrosinase inhibitory activity than norartocar-
petin because of its low polarity substituent groups. How-
ever, it should be noted that artocarpin exhibits higher
melanogenesis inhibitory activity in melanoma cells than
norartocarpetin even though artocarpin shows low tyrosi-
nase inhibitory activity, suggesting that it is necessity to
consider the expressions of melanogenic enzymes as well
as tyrosinase activity in melanoma cells. As described
above, a lot of tyrosinase inhibitors have been obtained and
investigated the mechanism. However, there are few re-
ports focusing on the compounds stimulating tyrosinase
activity thus far.
Regulator on expression of melanogenic enzymes
Tyrosinase is transcriptionally regulated by MITF, and
MITF expression is regulated by a number of kinase
pathways. Recently, the melanogenesis-regulating activity
of compounds have been evaluated by determining the
tyrosinase expression as well as tyrosinase activity. Be-
sides to clarify the mechanism, the expressions of MITF
and kinases have been investigated by western blot
analysis. 1-O-Methyl-fructofuranose from the fruit of
Schisandra chinensis is a traditional Korean medicinal
herb, and the effects of 1-O-methyl-fructofuranose on
melanogenesis, expressions of melanogenic enzymes, and
related signaling pathways were investigated. 1-O-
Methyl-fructofuranose inhibits melanogenesis by sup-
pressing the expressions of tyrosinase, TRP-1, and MITF.
Additionally, the study also elucidated the compound
increases the phosphorylation of ERK, suggesting 1-O-
methyl-fructofuranose inhibits melanogenesis by
stimulating the ERK pathway [46]. Citrus fruits press
cake was reported as melanogenesis inhibitor by sup-
pressing MITF expression [47]. Rhodiola rosea extracts
was studied as melanogenesis suppressor. The acetone
extract of R. rosea exhibits tyrosinase inhibitory activity
[48]. Besides R. rosea root containing phenylethanol
derivatives, phenylpropanoids, monoterpenes, flavonoids,
phenolic acids, and triterpenes [49, 50] decreases me-
lanin content in B16 melanoma cells via suppressing the
expressions of MC1R, a receptor of a-MSH, MITF,
TRP-1, and tyrosianse [51].
On the other hand, melanogenesis stimulator also has
been studied. Diethylstilbestrol was reported to exhibit
potent melanogenesis stimulatory activity. Diethylstilbe-
strol increases the tyrosinase, TRP-1, TRP-2, and MITF
mRNA as well as tyrosinase activity [52]. Cilostazol (6-[4-
(1-cyclohexyl-1 Htetrazol-5-yl)butoxy]-3,4-dihydro-2-
(1H)-quinolinone), known as an inhibitor of cAMP-de-
grading enzyme, promotes melanogenesis by increasing the



























Fig. 4 Chemical structures of
tyrosinase inhibitor including 2,
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Recently a number of papers have focused on the
modulation of tyrosinase activity and expressions of me-
lanogenic enzymes to control the skin and hair pigmenta-
tion. The skin and hair pigmentation takes place by the
melanosomes transported and released from melanocyte.
However, few studies have treated the compounds which
could control the transportation of melanosomes as well as
the expressions of melanogenic enzymes. Several proteins,
involved in the transportation of melanosomes, have been
identified and a lot of the mechanism of the transportation
has been already clarified. Therefore, the investigation of
regulators on transportation of melanosomes is desired.
Bioactivities of H. zeylanica extracts
To search the lead compounds modulating the melano-
genesis activity, H. zeylanica (Fig. 5) root extract has been
focused on because of the melanogenesis stimulatory ac-
tivity on the screening assay. H. zeylanica, which belongs
to Ophioglossaceae family, has been used for pain relief,
germ killing, wound care, and promotion of bone healing
after fracture [54, 55]. Besides it has been used as an an-
tipyretic, antiphlogistic, and anodyne [56] and used to treat
sciatica, boils, ulcers and malaria [57]. The bioactive
components included in H. zeylanica have been isolated
and identified so far. Four flavonoids, ugonins A–D were
isolated from rhizomes [58, 59]. Moreover, ugonins E–T
were isolated from root as antioxidant and anti-inflamma-
tory activity by Huang [60, 61]. Additionally, ugonin K
promoted osteoblastic differentiation and mineralization
via activating of p38 MAPK and ERK pathway [54].
Quercetin glycosides from H. zeylanica root
as intracellular melanogenesis stimulator
Two novel quercetin glycosides compound 1 and 2 (Fig. 6)
were isolated from a water/EtOH extract of H. zeylanica root
via column chromatography, and identified as 40-O-b-D-glu-
copyranosyl-quercetin-3-O-b-D-glucopyranosyl-(1 ? 4)-b-
D-glucopyranoside and 40-O-b-D-glucopyranosyl-(1 ? 2)-
b-D-glucopyranosyl-quercetin-3-O-b-D-glucopyranosyl-
(1 ? 4)-b-D-glucopyranoside, respectively, by NMR and
UPLC-TOFMS in our paper [62].
The intracellular melanogenesis enhancement activity of
compound 1 and 2 at 10 lM of concentration was inves-
tigated. The intracellular melanogenesis activity and cell
viability of compound 1 were 270 and 93 %, respectively,
while compound 2 has no intracellular melanogenesis en-
hancement activity without affecting tyrosinase activities.
Quercetin, the aglycon of compound 1 and 2, has high
intracellular melanogenesis inhibitory activity. However,
quercetin-40-O-b-D-glucoside, quercetin-3-O-b-D-glu-
coside, quercetin-3, 40-O-b-D-glucoside, and rutin showed a
lower inhibitory activity than quercetin [63]. However,
quercetin-3-O-b-D-glucoside enhances melanogenesis by
accelerating the expression of TRP-1 and -2 [64]. Our
Fig. 5 Helminthostachys zeylanica Fig. 6 Structures of quercetin derivatives
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results showed the similar and curious tendencies that 1 has
intracellular melanogenesis acceleration activity of 2.7
times to control, while interestingly compound 2 has no
intracellular melanogenesis enhancement activity in spite
of the similarity of the structure. This result means the
number of sugar connecting C-40 may play an important
role in the melanogenesis activity.
Tyrosinase is transcriptionally regulated by MITF and
its expression is activated by the p38 MAPK cascade. On
the other hand, ERK and JNK pathway have been reported
to be related to the down-regulation of melanin synthesis
[64]. Some melanogenic enhancing agents have been ex-
amined at several points of melanogenesis such as ex-
pression of tyrosinase, p38, JNK, ERK and MITF as well
as tyrosinase activity.
Synthesis of quercetin derivatives
and the melanogenesis stimulatory activity via p38
pathway
Quercetin is a flavonoid present as a glycoside in various
fruits and vegetables [65–67]. A number of studies have
demonstrated that quercetin exhibits a variety of pharma-
cological effects, including antioxidant and anti-cancer
activities [68, 69], while some reports relate to effective-
ness in controlling melanogenesis. Quercetin is recognized
as a potent inhibitor of tyrosinase activity and melano-
genesis, as evidenced by the studies performed in the
mouse B16 melanoma cells [70]. However, quercetin has
been reported to elicit the opposite effect and accelerate
melanogenesis in human melanoma cells [71]. Further-
more, it was reported that the direction of its melano-
genesis-regulating activity depends on the concentration of
quercetin used [72]. A small number of studies have shown
that quercetin derivatives can control melanogenesis.
Quercetin-3-O-b-D-glucoside enhances melanogenesis by
stimulating the expression of TRP-1 and TRP-2 [64].
Chemical synthesis of compounds isolated from natural
products plays an important role to obtain the abundant amount
of the compounds and to identify the exact chemical structure
of the compounds. The synthesis strategy of quercetin
derivatives has been studied so far because of their high po-
tency on biological activity. For instance, quercetin 3-O-b-D-
glucuronide was synthesized from rutin as a starting material
[73]. Regiospecific synthesis of quercetin-O-b-D-glucosylated
and quercetin-O-b-D-glucuronidated isomers using
dichlorodiphenylmethane to protect hydroxyl groups of cate-
chol moiety on B ring [74]. Additionally five O-monomethy-
lated analogs of quercetin (30-O-methylquercetin, 40-O-
methylquercetin, 3-O-methylquercetin, 5-O-methylquercetin,
and 7-O-methylquercetin) were synthesized through sequen-
tial protection using dichlorodiphenylmethane [75].
We synthesized twenty quercetin derivatives as shown
in Fig. 6 according to the previous papers to investigate the
structure–activity relationships of quercetin derivatives on
melanogenesis stimulatory activity.
The melanogenesis activities by adding the synthesized
quercetin glycosides were determined with measuring intra
and extracellular melanin content in B16 melanoma cells.
The data for cell viability and the melanogenesis activity of
B16 melanoma cells are shown in Table 1. Quercetin
glycosides 1, 3, and 4 showed intracellular melanogenesis
stimulatory activity in a dose-dependent manner, and their
activities were higher than that of theophyline used as
positive control [76]. Interestingly, the other quercetin
glycosides had little or no melanogenesis stimulatory ac-
tivity despite their structural similarities. The molecules
with 7-O-glycoside showed no intracellular melanogenesis
stimulatory activity. On the other hand, the molecules with
3-O-glucoside, with a free OH group on the B ring, and the
molecules with 3-O-cellobioside, with a free OH group or
40-O-glucoside showed intracellular melanogenesis
stimulatory activity. Thus, a hydroxyl group on C-7 may
play an important role in melanogenesis activity. Addi-
tionally, the chemical structure of the sugar connected at
the C-40 may also play an important role in the activity.
Moreover, it should be noted that the opposite effect was
reported that quercetin and quercetin-40-O-glucoside which
have the hydroxyl group at C-3 inhibited the melanin
biosynthesis [77]. These results indicated that the hydroxyl
group at C-3 of quercetin derivatives may be important to
suppress the melaninogenesis activity, and the effect for
melanin biosynthesis in B16 melanoma cells of quercetin
glycosides are varied significantly by the presence or ab-
sence of hydroxyl group especially combing to C-3 or C-7
position. Furthermore, the activity may be more complex
by the kind, size or polarity of the sugars connecting to the
quercetin, therefore it is necessity the further investigations
to elucidate completely the structure–activity relationships
of quercetin glycosides.
The effects of compounds 12–20 on cell viability and
melanogenesis are shown in Table 2. We evaluated the
modulation of intra and extracellular melanin levels by
quercetin methylethers with theophylline as a positive
control. On measuring the melanogenesis activity assay for
each compounds, we adopted a concentration which was
not shown strong cytotoxicity of the B16 melanoma cells.
As shown in Table 1, quercetin glycosides 1, 3, and 4
stimulated intracellular melanogenesis in a dose-dependent
manner. However, none of the synthesized quercetin gly-
cosides increased the extracellular levels of melanin. On
the other hand, quercetin methylethers 12–15 increased
both intra- and extracellular melanin content (Table 2),
demonstrating higher melanogenesis stimulation than
theophylline, a positive control. Significant effects were
356 J Wood Sci (2015) 61:351–363
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Table 1 Intra- and
extracellular melanogenesis
activity and cell viability in B16
melanoma cells by the
synthesized quercetin
glycosides 1–11
Cell viability and melanogenesis activity (%)
200 lM 100 lM 10 lM
1
Intercellular melanogenesis activity 190.5 ± 10.2* 151.5 ± 8.1* 137.0 ± 0.8*
Extracellular melanogenesis activity 125.5 ± 9.3 116.0 ± 12.6 99.7 ± 21.7
Cell viability 74.8 ± 2.1 86.8 ± 2.0 90.0 ± 6.9
3
Intercellular melanogenesis activity 206.9 ± 2.3** 157.1 ± 8.6* 116.3 ± 1.3
Extracellular melanogenesis activity 86.1 ± 2.7 85.1 ± 1.7 91.0 ± 4.1
Cell viability 68.4 ± 6.9* 80.9 ± 5.5 105.0 ± 3.8
4
Intercellular melanogenesis activity 176.0 ± 9.1* 126.8 ± 9.1* 102.6 ± 2.9
Extracellular melanogenesis activity 85.2 ± 4.9 91.0 ± 6.3 83.3 ± 5.8
Cell viability 81.1 ± 3.0 93.2 ± 0.6 99.6 ± 1.5
5
Intercellular melanogenesis activity 119.0 ± 7.4 78.9 ± 6.0 91.1 ± 5.5
Extracellular melanogenesis activity 93.3 ± 6.4 105.8 ± 3.3 102.4 ± 2.8
Cell viability 98.7 ± 12.4 112.6 ± 2.6 95.1 ± 1.6
6
Intercellular melanogenesis activity 99.7 ± 1.8 84.77 ± 2.1 79.7 ± 4.2
Extracellular melanogenesis activity 80.9 ± 3.8 92.3 ± 2.7 91.2 ± 2.0
Cell viability 99.7 ± 1.8 106.0 ± 8.3 106.8 ± 3.4
7
Intercellular melanogenesis activity 102.6 ± 15.5 97.8 ± 7.2 80.3 ± 2.14
Extracellular melanogenesis activity 96.9 ± 5.4 102.1 ± 0.6 93.0 ± 1.2
Cell viability 95.2 ± 0.4 93.9 ± 7.6 105.3 ± 0.7
8
Intercellular melanogenesis activity 92.6 ± 0.0 90.4 ± 15.1 89.7 ± 11.9
Extracellular melanogenesis activity 103.2 ± 11.7 95.0 ± 2.3 100.0 ± 3.5
Cell viability 77.4 ± 10.4 104.1 ± 3.5 107.3 ± 6.5
9
Intercellular melanogenesis activity 86.5 ± 9.1 113.9 ± 14.4 85.0 ± 1.5
Extracellular melanogenesis activity 74.6 ± 9.3 113.7 ± 0.5 103.2 ± 0.1
Cell viability 114.4 ± 4.8 78.0 ± 1.3 97.7 ± 2.5
10
Intercellular melanognenesis activity 96.3 ± 0.9 90.9 ± 13.3 96.8 ± 7.6
Extracellular melanogenesis activity 87.3 ± 12.6 95.1 ± 5.8 99.9 ± 3.8
Cell viability 105.6 ± 6.4 107.0 ± 2.6 97.8 ± 8.9
11
Intercellular melanogenesis activity 83.8 ± 1.9 78.9 ± 6.0 91.1 ± 5.5
Extracellular melanogenesis activity 91.9 ± 18.0 90.1 ± 2.1 104.5 ± 7.1
Cell viability 111.0 ± 9.6 112.6 ± 2.6 95.1 ± 1.6
Theophyline 500 lM 250 lM 125 lM
Intercellular melanogenesis activity 166.8 ± 31.7* 131.7 ± 1.9 127.6 ± 6.6
Extracellular melanogenesis activity 204 ± 1.6** 183.2 ± 3.2** 170.7 ± 0.7**
Cell viability 91.4 ± 1.3 94.4 ± 4.1 95.5 ± 11.0
Data are expressed as means ± SD (n = 2)
* p B 0.05 and ** p B 0.01 compared with respective control values
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Table 2 Intra- and extracellular melanogenesis activity and cell viability in B16 melanoma cells by the synthesized quercetin derivatives 12–20
Cell viability and melanogenesis activity (%)
50 lM 25 lM 12.5 lM 6.25 lM
12
Intercellular melanogenesis activity 157.3 ± 8.4* 146.5 ± 15.3 137.0 ± 23.6 –
Extracellular melanogenesis activity 224.9 ± 18.2* 130.8 ± 5.8* 124.1 ± 1.4 –
Cell viability 74.4 ± 3.8 88.1 ± 4.1 98.2 ± 6.7 –
13
Intercellular melanogenesis activity – 166.6 ± 0.0** 178.8 ± 9.6** 132.3 ± 8.1*
Extracellular melanogenesis activity – 346.7 ± 2.9** 309.5 ± 14.5** 229.5 ± 17.6*
Cell viability – 63.2 ± 2.1** 50.0 ± 0.5** 75.6 ± 2.9**
14
Intercellular melanogenesis activity – 187.6 ± 2.5** 171.2 ± 0.0** 134.0 ± 4.3*
Extracellular melanogenesis activity – 265.5 ± 5.9** 304.3 ± 4.0** 222.8 ± 12.8**
Cell viability – 54.1 ± 0.55** 60.4 ± 4.2** 80.4 ± 0.5**
15
Intercellular melanogenesis activity – 203.4 ± 3.4** 181.4 ± 9.0** 127.7 ± 4.3*
Extracellular melanogenesis activity – 298.7 ± 3.7** 228.0 ± 7.0** 225.5 ± 10.8**
Cell viability – 90.2 ± 4.3 101.9 ± 2.2 95.3 ± 1.8
16
Intercellular melanogenesis activity – 106.9 ± 7.1 133.5 ± 4.4 125.6 ± 5.7
Extracellular melanogenesis activity – 97.9 ± 0.0 95.1 ± 0.2 97.5 ± 2.2
Cell viability – 100.9 ± 1.3 103.0 ± 4.3 103.6 ± 3.6
17
Intercellular melanogenesis activity – 75.8 ± 12.9 87.6 ± 2.6 102.4 ± 12.0
Extracellular melanogenesis activity – 114.3 ± 1.1 105.2 ± 1.3 105.5 ± 1.4
Cell viability – 91.6 ± 4.5 99.4 ± 5.1 92.7 ± 0.5
18
Intercellular melanogenesis activity – 100.5 ± 10.0 106.1 ± 8.1 110.2 ± 2.5
Extracellular melanogenesis activity – 100.1 ± 0.3 98.0 ± 0.0 100.5 ± 0.5
Cell viability – 101.3 ± 3.7 101.4 ± 1.9 99.7 ± 1.2
19
Intercellular melanogenesis activity 104.6 ± 3.1 114.3 ± 3.6 99.0 ± 8.3 –
Extracellular melanogenesis activity 126.6 ± 2.3 102.6 ± 6.2 87.6 ± 5.1 –
Cell viability 110.0 ± 7.9 120.4 ± 0.3 110.0 ± 3.8 –
20
Intercellular melanogenesis activity 148.4 ± 1.4** 121.4 ± 17.1 122.4 ± 2.1 –
Extracellular melanogenesis activity 96.1 ± 1.8 101.5 ± 1.4 89.3 ± 0.4 –
Cell viability 103.7 ± 1.1 101.8 ± 0.2 113.5 ± 8.1 –
Theophyline 500 lM 250 lM 125 lM
Intercellular melanogenesis activity 166.8 ± 31.7* 131.7 ± 1.9 127.6 ± 6.6
Extracellular melanogenesis activity 204.0 ± 1.6** 183.2 ± 3.2** 170.7 ± 0.7**
Cell viability 91.4 ± 1.3 94.4 ± 4.1 95.5 ± 11.0
Data are expressed as means ± SD (n = 2)
–, not done
* p B 0.05 and ** p B 0.01 compared with respective control values
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observed on the extracellular melanin levels. Comparing
the activities of compounds 12–15, medium of cells incu-
bated with 50 lM of compound 12 showed 224.9 % higher
extracellular melanin levels compared to controls. The in-
creases of melanin levels following incubation with com-
pounds 13–15 were higher than 220 %, even at 6.25 lM,
indicating the most potent stimulation of extracellular
melanin levels in this study. Furthermore, the 3-hydroxyl
quercetin methylethers such as 16–18, 3-O-acethyl-
quercetin 19, and quercetin-3-O-b-D-2,3,4,6-tetra-O-ace-
toglucopylanoside 20 showed no stimulatory effect on the
extracellular melanin levels, suggesting that the 3-meth-
oxyl group of compounds 12–15 is an essential moiety for
stimulation activity. Additionally, the 40 and/or 7-methoxyl
group may further increase the melanogenesis-stimulating
activity. Compounds 13–15 showed more potent melano-
genesis-stimulating activity compared to 12. Importantly,
13 and 14 were associated with high cell cytotoxicity in the
cell viability studies, while 15 exhibited high cell viability.
These differences in cell cytotoxicity between the quercetin
methylethers may depend on the presence of both 40 and
7-methoxyl groups. These results are described in the
previous published [78].
To understand the involvement of the tyrosinase enzyme
in the stimulation of melanogenesis, the activity of mush-
room tyrosinase was measured following incubation with
quercetin derivatives. However, no effect on tyrosinase
activity was observed with any of the quercetin derivatives
synthesized in this study (data not shown). Therefore, the
quercetin methylethers may contribute to the expression of
tyrosinase or related genes in B16 melanoma cells.
Effect of compounds 12 and 15 on the expression
of proteins involved in melanin biosynthesis
In general, the signaling pathway modulating the expres-
sion of melanogenic enzymes in melanoma cells comprises
the following steps. First, extracellular messengers, such as
a-MSH and histamine, interact with receptors on the me-
lanocyte. Receptor stimulation increases intracellular
cAMP levels in the melanocyte, stimulating a number of
intracellular kinase pathways, such as the p38 MAPK,
ERK, and JNK. These kinase signaling cascades regulate
the expression of MITF, which acts as a transcriptional
factor regulating the expression of tyrosinase, TRP-1, and
TRP-2.
Some studies have reported that melanogenesis-
modulating agents regulate the expression of tyrosinase,
TRP-1, and TRP-2 by regulating the expression of p38
MAPK, ERK, JNK, and MITF. For example, the compo-
nents isolated from Nardostachys chinensis and Rhodiola
rosea crude extracts were reported to inhibit melanin
biosynthesis by suppressing the expression of MITF and
tyrosinase in B16 melanoma cells. Similarly, the com-
pounds showing melanogenesis-stimulating activity in this
study may also control the levels of tyrosinase and the
proteins that modulate its expression, as suggested by the
observation that the stimulatory activity does not depend
on the tyrosinase activity.
As presented in Table 2, compound 15 showed sig-
nificant intra- and extracellular melanogenesis-stimulating
activity, with low cytotoxicity. The effects of compound 15
on the expressions of proteins related to melanin biosyn-
thesis, such as tyrosinase, TRP-1, TRP-2, MITF, p-p38
MAPK, and p38 MAPK were investigated to identify the
specific biosynthetic step associated with its activity. As
shown in Fig. 7, 15 increased the expression of tyrosinase,
TRP-1, TRP-2, MITF, and p-p38 MAPK in a dose-de-
pendent manner in B16 melanoma cells. Conversely, the
expression of p38 MAPK was not increased by 15, indi-
cating that it stimulates melanin biosynthesis by stimulat-
ing the p38 MAPK phosphorylation. Furthermore, the
melanogenesis-stimulating effects of 12 were determined
to compare the activity on the expression of the proteins.
Comparing the activities of 12 and 15 on the expression of
proteins related to melanin biosynthesis, 12 was found to
increase the expression ratio of the tyrosinase and TRP-1 to
a greater extent than 15. Nevertheless, extracellular me-
lanogenesis-stimulating activity of 12 was lower than that
of 15 (Table 2), suggesting that melanogenesis in me-
lanoma cells is not solely dependent on the expression of
tyrosinase and TRP-1. Furthermore, 15 significantly
stimulated the expression of MITF and p-p38 MAPK,
which enhance the expression of tyrosinase, TRP-1, and
TRP-2. Conversely, 12 did not alter the expression of
MITF and p-p38 MAPK, despite enhancing the expression
of tyrosinase, TRP-1, and TRP-2. Except for MITF, no
transcriptional factors controlling tyrosinase expression
have been reported thus far. These results may therefore
indicate that 12 enhances the expression of tyrosinase,
TRP-1, and TRP-2 by stimulating transcriptional factors
that are yet to be identified. The levels of melanogenic
enzymes in the melanocyte are also regulated by protein
degradation by proteasome through ubiquitination [26].
Fatty acids, a major component of the cell membranes,
were previously reported to regulate melanin biosynthesis
by controlling the degradation of tyrosinase, TRP-1, and
TRP-2 [79]. Therefore, in addition to the possible effect on
a transcriptional factor, an alternative explanation for the
enhancing activity of 12 on the levels of melanogenic en-
zymes may involve the inhibition of the degradation of
melanogenic enzymes through ubiquination. Compared to
15, 12 increased the expression of melanogenic enzymes,
but showed less melanogenesis-stimulating activity, as
described above. Additionally, the levels of p-p38 MAPK
J Wood Sci (2015) 61:351–363 359
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and MITF were not increased by the addition of 12. If the
two phenomena were related to each other, MITF and/or
p-p38 MAPK may play an important role in the regulation
of melanogenesis not only by enhancing the expressions of
the enzymes, but also through affecting other factors, such
as the transportation and/or degradation of melanogenic
enzymes.
Tyrosinase, TRP-1, and TRP-2 are expressed through a
MITF-regulated process and transported to the me-
lanosome. Melanin is biosynthesized in the melanosome by
the action of the melanogenic enzymes. The mature me-
lanosome is specifically transported to the periphery of the
cell from the perinuclear region of the melanocytes through
a process that involves a wide variety of cellular transport
proteins, including actin, myosin Va, Rab27A, and Slac2-a.
Compound 15 may accelerate the transportation of
melanogenic enzymes to the melanosome and/or trans-
portation of melanosome to the outside of the cells by
regulating the expression of proteins related to cellular
transport. However, 12 may elicit less potent stimulation of
the transportation of melanogenic enzymes to the me-
lanosome and/or the transportation of melanosome as
compared to 15.
Among the nineteen synthesized compounds, 1, 3, and 4
are quercetin glycosides exhibiting intracellular melano-
genesis stimulatory activity, while they showed no effect
on extracellular melanogenesis. On the other hand, 12 and
15 increased both intra and extracellular melanin contents
more potently than the positive control theophylline, with
exhibiting low cytotoxicity. Compound 12 exhibited less
melanogenesis-stimulating activity than compound 15.






































































































Fig. 7 Effect of 12 and 15 on the expression of Tyrosinase, TRP1,
TRP2, MITF, p-p38MAPK, and p38MAPK in B16 melanoma cells.
a Representative blots of 12. b Quantification of the ratio of protein
expressions in melanoma cells treated by 12. The data show the
mean ± SD from three independent experiments. c Representative
blots of 15. d Quantification of the ratio of protein expressions in
melanoma cells treated by 15. The data show the mean ± SD from
three independent experiments. *p B 0.05 and **p B 0.01 compared
with control values
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TRP-1 to a greater extent than 15, thereby suggesting that
melanogenesis in melanoma cells does not depend solely
on the expression of the enzymes catalyzing melanin
biosynthesis. Furthermore, 15 also stimulated the expres-
sion of the MITF and p-p38 MAPK, while they were not
increased by 12. These results suggest that 12 may enhance
the expression of tyrosinase and TRP-1 by regulating the
proteasomal degradation of melanogenic enzymes and/or
by activating other transcriptional factors regulating en-
zyme expression.
References
1. Lukiewicz S (1972) The biological role of melanin I: new con-
cepts and methodological approaches. Folia Histochemica Cyto-
chemica 10:93–108
2. Wang H, Pan Y, Tang X, Huang Z (2006) Isolation and char-
acterization of melanin from Osmanthus fragrans’ seeds. LWT-
Food Sci Technol 39:496–502
3. Rees JL (2003) Genetics of hair and skin color. Annu Rev Genet
37:67–90
4. Yoshida M, Takahashi T, Inoue S (2000) Histamine induces
melanogenesis and morphologic changes by protein kinase A
activation via H2 receptors in human normal melanocytes. J In-
vest Dermatol 114:334–342
5. Bu J, Ma PC, Chen ZQ, Zhou W, Fu YJ, Li LJ, Li CR (2008)
Inhibition of MITF and tyrosinase by paeonol-stimulated JNK/
SAPK to reduction of phosphorylated CREB. Am J Chin Med
36:245–263
6. Slominski A, Paus R (1993) Melanogenesis is coupled to murine
anagen: toward new concepts for the role of melanocyte and the
regulation of melanogenesis in hair growth. J Invest Dermatol
101:90S–97S
7. Tobin DJ, Hagen E, Botchkarev VA, Paus R (1998) Do hair bulb
melanocytes undergo apotosis during hair follicle regression
(catagen)? J Invest Dermatol 111:941–947
8. Slominski A, Paus R, Plonka P, Chakraborty A, Maurer M, Pruski
D, Lukiewicz S (1994) Melanogenesis during the anagen-cata-
gen-telogen transformation of the murine hair cycle. J Invest
Dermatol 102:862–869
9. Tobin DJ, Slominski A, Botchkarev V, Paus R (1999) The fate of
hair follicle melanocytes during the hair growth cycle. J Invest
Dermatol Symp Proc 4:323–332
10. Guo H, Fang YK, Jixing D, Yizhan Y, Yuhong Xiaohua L, Yang TL
(2012) Wnt3a promotes melanin synthesis of mouse hair follicle
melanocytes. Biochem Biophys Res Commun 420:799–804
11. Prota G (1995) The chemistry of melanins and melanogenesis.
Fortsch Chem Organ Natur 64:93–148
12. Alvaro FS, Jos RLN, Francisco CG (1995) Tyrosinase: a com-
prehensive review of its mechanism. Biochim Biophys Acta
1247:1–11
13. Cooksey CJ, Garratt PJ, Land EJ, Ramsden CA, Riley PA (1998)
Tyrosinase kinetics: failure of the auto-activation mechanism of
monohydric phenol oxidation by rapid formation of a quino-
methane intermediate. Biochem J 333:685–691
14. Ye Y, Chou GX, Wang H, Chu JH, Yu ZL (2010) Flavonoids,
apigenin and icariin exert potent melanogenic activities in murine
B16 melanoma cells. Phytomedicine 18:32–35
15. Aksan I, Goding CR (1998) Targeting the microphthalmia basic
helix-loop-helix–leucine zipper vtranscription factor to a subset
of E-box elements in vitro and in vivo. Mol Cell Biol
18:6930–6938
16. Bertolotto C, Bile K, Ortonne JP, Ballotti R (1998) In B16 me-
lanoma cells, the inhibition of melanogenesis by TPA results
from PKC activation and diminution of microphthalmia binding
to the M-box of the tyrosinase promoter. Oncogene
16:1665–1670
17. Tachibana M, Takeda K, Nobukuni Y, Urabe K, Long JE, Meyers
KA, Aaronson SA, Miki T (1996) Ectopic expression of MITF, a
gene for Waardenburg syndrome type 2, converts fibroblasts to
cells with melanocyte characteristics. Nat Genet 14:50–54
18. Karin M (1995) The regulation of AP-1 activity by mitogen-
activated protein kinases. J Biol Chem 270:16483–16486
19. Weston CR, Davis RJ (2007) The JNK signal transduction
pathway. Curr Opin Cell Biol 19:142–149
20. Busca` R, Abbe P, Mantoux F, Aberdam E, Peyssonnaux C, Ey-
che`ne A, Ortonne JP, Ballotti R (2000) Ras mediates the cAMP-
dependent activation of extracellular signal-regulated kinases
(ERKs) in melanocytes. EMBO J 19:2900–2910
21. Bertolotto C, Abbe P, Hemesath TJ, Bille K, Fisher DE, Ortonne
JP, Ballotti R (1998) Microphthalmia gene product as a signal
transducer in cAMP-Induced differentiation of melanocytes.
J Cell Biol 142:827–835
22. Bertolotto C, Busca` R, Abbe P, Bile K, Aberdam E, Ortonne JP,
Ballotti R (1998) Different cis-acting elements are involved in the
regulation of TRP1 and TRP2 promoter activities by cyclic AMP:
pivotal role of M boxes (GTCATGTGCT) and of microph-
thalmia. Mol Cell Biol 18:694–702
23. Jang YJ, Kim NH, Kim RY, Choi WY, Choi HY, Shin KH, Choi
TB (2011) Partially purified components of Nardostachys chi-
nensis suppress melanin synthesis through ERK and Akt signal-
ing pathway with cAMP down-regulation in B16F10 cells.
J Ethnopharmacol 137:1207–1214
24. Jiang Z, Xu J, Long M, Tu Z, Yang G, He G (2009) 2,3,5,40-
tetrahydroxystilbene-2-O-beta-D-glucoside (THSG) induces me-
lanogenesis in B16 cells by MAP kinase activation and tyrosinase
upregulation. Life Sci 85:345–350
25. Park SY, Kim YH, Kim YH, Park G, Lee SJ (2010) Beta-car-
boline alkaloids harmaline and harmalol induce melanogenesis
through p38 mitogen-activated protein kinase in B16F10 mouse
melanoma cells. BMB Rep 43:824–829
26. Bellei B, Maresca V, Flori E, Pitisc A, Larue L, Picardo M (2010)
p38 regulates pigmentation via proteasomal degradation of ty-
rosinase. J Biol Chem 285:7288–7299
27. Englaro W, Bertolotto C, Busca R, Brunet A, Pages G, Ortonne
JP, Ballotti R (1998) Inhibition of the mitogen-activated protein
kinase pathway triggers B16 melanoma cell differentiation. J Biol
Chem 273:9966–9970
28. Roberts PJ, Der CJ (2007) Targeting the Raf-MEK-ERK mito-
gen-activated protein kinase cascade for the treatment of cancer.
Oncogene 26:3291–3310
29. Yoon S, Seger R (2006) The extracellular signal-regulated ki-
nase: multiple substrates regulate diverse cellular functions.
Growth Factors 24:21–44
30. Lopez-Bergami P (2011) The role of mitogen- and stress-acti-
vated protein kinase pathways in melanoma. Pigment Cell Me-
lanoma Res 24:902–921
31. Bu J, Ma PC, Chen ZQ, Zhou WQ, Fu YJ, Li LJ, Li CR (2008)
Inhibition of MITF and tyrosinase by paeonol-stimulated JNK/
SAPK to reduction of phosphorylated CREB. Am J Chin Med
36:245–263
32. Mingo-Sion AM, Marietta PM, Koller E, Wolf DM, Van Den
Berg CL (2004) Inhibition of JNK reduced G2/M transit inde-
pendent of p53, leading to endoreduplication, decreased prolif-
eration, and apoptosis inbreast cancer cells. Oncogene
23:596–604
J Wood Sci (2015) 61:351–363 361
123
33. Uzgare RA, Isaccs TJ (2004) Enhanced redundancy in Akt and
Mitogen-activated protein kinase-induced survival of malignant
versus normal prostate epithelial cells. Cancer Res 64:6190–6199
34. Elfahmi Woerdenbag JH, Kayser O (2014) Jamu: Indonesian
traditional herbal medicine towards rational phytopharmaco-
logical use. J Herbal Med 4:51–73
35. Kamiya K, Saiki Y, Hama T, Fujimoto Y, Endang H, Umar M,
Satake T (2001) Flavonoid glucuronides from Helicteres isora.
Phytochemistry 57:297–301
36. Kubo I, Murai Y, Soediroa I, Soetarnoa S, Sastrodihardjoa S
(1992) Cytotoxic anthraquinones from Rheum palmatum. Phy-
tochemistry 31:1063–1065
37. Ikawati Z, Wahyuono S, Maeyam K (2001) Screening of several
Indonesian medicinal plants for their inhibitory effect on his-
tamine release from RBL-2H3 cells. J Ethnopharmacol
75:249–256
38. Mendoza-Wilson AM, Santacruz-Ortega H, Balandra´n-Quintana
RR (2011) Relationship between structure, properties, and the
radical scavenging activity of morin. J Mol Struct 995:134–141
39. Wang Y, Zhang G, Yan J, Gong D (2014) Inhibitory effect of
morin on tyrosinase: insights from spectroscopic and molecular
docking studies. Food Chem 163:226–233
40. Yamauchi K, Mitsunaga T, Batubara I (2011) Isolation, identi-
fication and tyrosinase inhibitory activities of the extractives from
Allamanda cathartica. Natural Resources 2:167–172
41. Nerya O, Vaya J, Musa R, Izrael S, Ben-Arie R, Tamir S (2003)
Glabrene and Isoliquiritigenin as Tyrosinase Inhibitors from Li-
corice Roots. J Agric Food Chem 51:1201–1207
42. Shimizu K, Kondo R, Sakai K, Lee SH, Sato H (1998) The
inhibitory components from Artocarpus incisus on melanin
biosynthesis. Planta Med 64:408–412
43. Shimizu K, Kondo R, Sakai K (2000) Inhibition of tyrosinase by
flavonoids, stilbenes and related 4-substituted resorcinols: struc-
ture-activity investigations. Planta Med 66:11–15
44. Lan WC, Tzeng CW, Lin CC, Yen FL, Ko HH (2013) Prenylated
flavonoids from Artocarpus altilis: antioxidant activities and in-
hibitory effects on melanin production. Phytochemistry 89:78–88
45. Adewole SO, Ojewole JO (2007) Hyperglycaemic effect of Ar-
tocarpus communis Forst. (Moraceae) root bark aqueous extract
in Wistar rats: cardiovascular topic. Cardiovasc J Afr 18:221–227
46. Oh EY, Jang JY, Choi YH, Choi YW, Choi BT (2010) Inhibitory
effects of 1-O-methyl-fructofuranose from Schisandra chinensis
fruit on melanogenesis in B16F0 melanoma cells. J Ethno
132:219–224
47. Kim SS, Kim MJ, Choi YH, Kim KS, Park KJ, Park SM, Lee NH,
Hyun CG (2013) Down-regulation of tyrosinase, TRP-1, TRP-2
and MITF expressions by citrus press-cakes in murine B16 F10
melanoma. Asian Pac J Trop Biomed 3:617–622
48. Chen CH, Chan HC, Chu YT, Ho HY, Chen PY, Lee TH, Lee CK
(2009) Antioxidant activity of some plant extracts towards xan-
thine oxidase, lipoxygenase and tyrosinase. Molecules
14:2947–2958
49. Saratikov A, Krasnov E, Khnikina L, Duvidson L (1967) Isola-
tion and chemical analysis of individual biologically active
constituents of Rhodiola rosea. Proc Siberian Acad Sci Biol
1:54–60
50. Kurkin V, Zapesochnaya G (1985) Chemical composition and
pharmacological characteristics of Rhodiola rosea [review].
J Med Plants 1231–1445
51. Chiang HM, ChienYC WuCH, Kuo YH, Wu WC, Pan YY, Su
YH, Wen KC (2014) Hydroalcoholic extract of Rhodiola rosea L.
(Crassulaceae) and its hydrolysate inhibit melanogenesis in
B16F0 cells by regulating the CREB/MITF/tyrosinase pathway.
Food Chem Toxicol 65:129–139
52. Jian D, Jiang D, Su J, Chen W, Hu X, Kuang Y, Xie H, Li J, Chen
X (2011) Diethylstilbestrol enhances melanogenesis via cAMP-
PKA-mediating up-regulation of tyrosinase and MITF in mouse
B16 melanoma cells. Steroids 76:1297–1304
53. Wei B, Zhang YP, Yan HZ, Xu Y, Du TM (2014) Cilostazol
promotes production of melanin by activating the microph-
thalmia-associated transcription factor (MITF). Biochem Biophys
Res Commun 443:617–621
54. Lee CH, Huang YL, Liao JF, Chiou WF (2011) Ugonin K pro-
motes osteoblastic differentiation and mineralization by activa-
tion of p38 MAPK- and ERK-mediated expression of Runx2 and
osterix. Eur J Pharmacol 668:383–389
55. Lee CH, Huang YL, Liao JF, Chiou WF (2012) Ugonin K-s-
timulated osteogenesis involves estrogen receptor-dependent ac-
tivation of non-classical Src signaling pathway and classical
pathway. Eur J Pharmacol 676:26–33
56. Chiu NY, Chang KH (1992) The illustrated medicinal plants of
taiwan, 3rd edn. SMC Publishing Inc, Taipei, p 18
57. Suja SR, Latha PG, Pushpangadan P, Rajasekharan S (2004)
Evaluation of hepatoprotective effects of Helminthostachys zey-
lanica (L.) Hook against carbon tetrachloride-induced liver
damage in Wistar rats. J Ethnopharmac 92:61–66
58. Murakami T, Hagiwara M, Tanaka K, Chen CM (1973)
Chemische untersuchungen u¨ber die inhaltsstoffe von Hel-
minthostachys zeylanica (L.) Hook I. Chem Pharm Bull
21:1849–1851
59. Murakami T, Hagiwara M, Tanaka K, Chen CM (1973)
Chemische untersuchungen u¨ber die inhaltsstoffe von Hel-
minthostachys zeylanica (L.) Hook II. Chem Pharm Bull
21:1851–1852
60. Huang YL, Yeh PY, Shen CC, Chen CC (2003) Antioxidant
flavonoids from the rhizomes of Helminthostachys zeylanica.
Phytochemistry 64:1277–1283
61. Huang YT, Hwang C, Chang Y, Yang C, Shen W, Liao S, Chen
C, Liaw (2009) Antiinflammatory flavonoids from the rhizome of
Helminthostachys zeylanica. J Nat Prod 72:1273–1278
62. Yamauchi K, Mitsunaga T, Batubara I (2013) Novel quercetin
glucosides from Helminthostachys zeylanica root and accel-
eratory activity of melanin biosynthesis. J Nat Med 67:369–374
63. Arung ET, Furuta S, Ishikawa H, Kusuma WI, Shimizu K, Kondo
R (2011) Anti-melanogenesis properties of quercetin- and its
derivative-rich extract from Allium cepa. Food Chem
124:1024–1028
64. Ye Y, Chu JH, Wang H, Xu H, Chou GX, Leung KMA, Fon WF,
Yu ZL (2010) Involvement of p38 MAPK signaling pathway in
the anti-melanogenic effect of San-bai-tang, a Chinese herbal
formula, in B16 cells. J Ethnopharmacol 132:533–535
65. Hertog GLM, Hollman HPC, Katan MB (1992) Intake of po-
tentially anticarcinogenic flavonoids and their determinants in
adults in the Netherlands. J Agric Food Chem 40:2379–2383
66. Hollman CHP, Katan BM (1999) Dietary flavonoids: intake,
health effects and bioavailability. Food Chem Toxicol
37:937–942
67. Manach C, Scalbert A, Morand C, Re´me´sy C, Jimenez L (2004)
Polyphenols: food sources and bioavailability. Am J Cli Nutr
79:727–747
68. Gibellini L, Pinti M, Nasi M, DeE Roat BS, Bertoncelli L,
Cossarizza A (2009) Interfering with ROS metabolism in cancer
cells: the potential role of quercetin. Cancers 2:1288–1311
69. Chen QX, Kubo IJ (2002) Kinetics of mushroom tyrosinase in-
hibition by quercetin. Agric Food Chem 50:4108–4112
70. Fuji T, Saito M (2009) Inhibitory effect of quercetin isolated from
rose hip (Rosa canina L.) against melanogenesis by mouse me-
lanoma cells. Biosci Biotechnol Biochem 9:1989–1993
71. Nagata H, Takekoshi S, Takeyama R, Homma T, Osamura YR
(2004) Quercetin enhances melanogenesis by increasing the ac-
tivity and synthesis of tyrosinase in human melanoma cells and in
normal human melanocytes. Pigment Cell Res 17:66–73
362 J Wood Sci (2015) 61:351–363
123
72. Yang YM, Son YO, Lee SA, Jeon YM, Lee JC (2011) Quercetin
inhibits a-MSH-stimulated melanogenesis in B16F10 melanoma
cells. Phytother Res 25:1166–1173
73. Kajjout M, Zemmouri R, Rolando C (2011) An expeditious
synthesis of quercetin 3-O-b-D-glucuronide from rutin. Tetrahe-
dron Lett 52:4738–4740
74. Kajjout M, Rolando C (2011) Regiospecific synthesis of quer-
cetin O-b-d-glucosylated and O-b-d-glucuronidated isomers.
Tetrahedron 67:4731–4741
75. Bouktaib M, Lebrun S, Atmani A, Rolando C (2002) Hemisyn-
thesis of all the O-monomethylated analogues of quercetin in-
cluding the major metabolites, through selective protection of
phenolic functions. Tetrahedron 58:10001–10009
76. Yamauchi K, Mitsunaga T, Batubara I (2014) Synthesis of
quercetin glycosides and their melanogenesis stimulatory activity
in B16 melanoma cells. Bioorg Med Chem 22:937–944
77. Arung ET, Matsubara E, Kusuma IW, Sukaton E, Shimizu K,
Kondo R (2011) Inhibitory components from the buds of clove
(Syzygium aromaticum) on melanin formation in B16 melanoma
cells. Fitoterapia 82:198–202
78. Yamauchi K, Mitsunaga T, Inagaki M, Suzuki T (2014) Syn-
thesized quercetin derivatives stimulate melanogenesis in B16
melanoma cells by influencing the expression of melanin
biosynthesis proteins MITF and p38 MAPK. Bioorg Med Chem
22:3331–3340
79. Ando H, Watabe H, Valencia JC, Yasumoto K, Furumura M,
Funasaka Y, Oka M, Ichihashi M, Hearing VJ (2004) Fatty acids
regulate pigmentation via proteasomal degradation of tyrosinase:
a new aspect of ubiquitin-proteasome function. J Biol Chem
279:15427–15433
J Wood Sci (2015) 61:351–363 363
123
